Neurovalens

About:

Neurovalens delivers innovative solutions in the field of neuroscience, bioscience and neurophysiology

Top Investors: British Business Bank, MedTech Innovator, Future Fund, Techstart Ventures, IQ Capital

Description:

Neurovalens delivers innovative solutions in the field of neuroscience, bioscience and neurophysiology.Neurovalens has received support from Invest NI under the European Union’s Investment for Growth and Jobs Programme. The project, recorded on the ERDF beneficiaries’ website, will be implemented over the next one year, undertaking research and development activities aimed at improving the competitiveness of the business.

Total Funding Amount:

$19.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Belfast, Belfast, United Kingdom

Founded Date:

2013-01-01

Founders:

Jason McKeown, Paul McGeoch

Number of Employees:

1-10

Last Funding Date:

2024-04-08

IPO Status:

Private

Industries: